(Total Views: 595)
Posted On: 05/08/2020 11:29:06 PM
Post# of 148935
Odddog wote:
Abstract:
In the second clinical trial, about 300 patients from around the world with serious cases of COVID-19 will be given doses of Leronlimab. Novant Health’s Chief Scientific Officer Dr. Steven Limentani says Novant Health has already started screening patients to be a part of the study.
Quote:
Novant Health joins second clinical trial testing medication to treat serious cases of COVID-19
Abstract:
In the second clinical trial, about 300 patients from around the world with serious cases of COVID-19 will be given doses of Leronlimab. Novant Health’s Chief Scientific Officer Dr. Steven Limentani says Novant Health has already started screening patients to be a part of the study.
(1)
(0)Scroll down for more posts ▼
